Sort by
Refine Your Search
-
field as well as a vibrant start-up scene. Starting in 2026, the International Max Planck Research School (link to https://www.mpg.de/de/imprs ) for Privacy-Enhancing Technologies for the Digital Society
-
successes may include, for example, those in the fields of research, teaching, science and society, knowledge and technology transfer, inventions and patents, software development or spin-offs. The position
-
The Max Planck Institute of Immunobiology and Epigenetics in Freiburg (Germany) has an opening for a scientist in proteomics in the research group of Dr. Gerhard Mittler (https://www.ie
-
Biochemistry (IPB, https://www.ipb-halle.de/en/ ) the following position is to be filled ideally on October 1st, 2027: Full Professor (Chair, W3) of Chemistry of Natural Products and Bioactives und Director at
-
, oncogenesis research, biomarker development, imaging, and cancer survivorship research, thereby focusing on questions of high relevance to the implementation of early detection programs at the individual and
-
recognition, and enable seamless collaboration between humans and machines. Long-Term Human-Technology Evolution: investigate the longitudinal impact of human-technology interaction on learning, behavior, and
-
W3 Endowed Professorship for “Hemodynamic Modeling in Atherosclerosis- (f/m/d) KSB Foundation W3 end
and teaching, the professorship will represent functional cardiovascular imaging with a focus on hemodynamic modeling and act as a bridge between basic research, medical technology development, and
-
bio-based circular economy. Its main research areas include microbial and enzymatic conversion processes as well as bioprocess development. IBG-1 is part of the Institute of Bio- and Geosciences, where
-
novel therapeutic targets for cancer and to make them usable for therapeutic approaches. A central focus lies on the development of innovative radiotracers and radiopharmaceuticals for diagnostic and
-
biology and immunology. They will research the role of the tumor microenvironment in tumor progression and the development of therapy resistance in solid tumors in the thorax. Of particular interest is